Neuracle Genetics has officially rebranded as 'Elisigen' to mark a new chapter in its growth. The new name reflects the company's commitment to addressing the root causes of diseases through gene therapy and reinforces its identity as a global biotechnology leader.
Read Original Article (Korean)
*Note: This link will redirect you to the original source in Korean.